MedTrace Logo

Treatment of Chronic Anemia With Epoetin Alfa in Elderly

NCT00337441 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2006-06-16

No results posted yet for this study

Summary

The purpose of this study is to determine if chronic anemia can be corrected with epoetin alfa and does the subsequent correction lead to an improvement in fatigue,quality of life or mobility among elderly.

Conditions

Interventions

DRUG

Epoetin Alfa (drug)

Sponsors & Collaborators

  • Ortho Biotech Clinical Affairs, L.L.C.

    collaborator INDUSTRY

  • Cook County Health

    collaborator OTHER_GOV

  • Mercy Hospital and Medical Center, Illinois

    collaborator OTHER

  • Research and Education Foundation of Michael Reese Hospital

    lead OTHER

Principal Investigators

  • Parag Agnihotri · Research and Education Foundation of Michael Reese

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Completion
2005-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00337441 on ClinicalTrials.gov